Amgen acquires stake in BeiGene to expand cancer drug business to China
RUBY WALLAU FOR STAT
For BeiGene, the partnership bolsters its existing commercial operations in China, which already sells certain cancer medicines owned by Celgene.
Desarrollan un dron que corre para despegar
Hace 1 minuto
No hay comentarios:
Publicar un comentario